English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Eli Lilly announces expanded partnership with Insilico Medicine in AI drug development deal
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Biogen’s lupus drug shows reduced disease activity in mid-stage trial results
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Merck advances Winrevair to pivotal study after mid-stage heart failure trial results
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

FDA approves high-dose Spinraza for spinal muscular atrophy treatment
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

AbbVie maintains confidence in Skyrizi after FDA approval of Icotyde for plaque psoriasis
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Takeda restructuring could affect more than 600 US employees, company says
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Lilly and Baseline investigate GLP-1 drugs for substance use disorders as research grows
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Kardigan blood pressure drug advances after mixed Phase 2 trial results

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones